Pediatrics Doctors in Americus, GA Accepting Medicare

6 Pediatrics doctors found. Showing 1 - 6

Zulfiqar Ali, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 609 E Lamar St, Americus, GA 31709 Phone: 229-924-8636    Fax: 229-924-8786

Dr. Nelson Tan Madrazo, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 103 Ga Highway 27 E, Americus, GA 31709 Phone: 229-924-8082    Fax: 229-924-8009

Dr. Quaison Trentus Dey, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 609 E Lamar St, Americus, GA 31709 Phone: 229-924-8636

Dr. Charles Alonzo Peters Jr., MD / PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 609 E Lamar St, Americus, GA 31709 Phone: 229-924-8636    Fax: 229-924-8786

Dr. Madelaine Odette Santos-vega, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 609 East Lamar Street, Americus, GA 31709 Phone: 229-924-8636    Fax: 229-924-8786

Yueh-ying Cheng, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 319 S Lee St, Americus, GA 31709 Phone: 229-924-9301    Fax: 229-924-9301

News Archive

CIHR, RX&D - HRF to fund research projects on mental illness, palliative care

Six research projects on co-existing heath problems associated with mental illness and one project on palliative care among First Nations received over $9 million in funding announced today. This amount is provided by the Canadian Institutes of Health Research and the Rx&D Health Research Foundation.

Myriad to acquire technology for diagnosis, prognosis of malignant melanoma

Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.

Scientists make important breakthrough in fight against debilitating autoimmune diseases

Scientists have made an important breakthrough in the fight against debilitating autoimmune diseases such as multiple sclerosis by revealing how to stop cells attacking healthy body tissue.

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

Read more Medical News

› Verified 8 days ago